Project opportunities
Functional genomics solutions powered by geneSlice — from target validation to clinical trial design.
Most of our projects are built on geneSlice™, our proprietary gene editing platform. The platform is the same; what varies is the question, the gene, the variant space, and the readout. The services below describe the most common project shapes we work on. If your project doesn't fit into one of them, Custom Services is the right entry point. Our team — experts in cell model engineering, gene editing from Cas9 to Prime Editing, functional assays, and bioinformatics — will develop a project tailored to your needs.
| Service | Who it's for | What you receive | |
|---|---|---|---|
| Oncology | Pharma and biotech with cancer drug projects | Variant-level drug sensitivity data for patient stratification, label expansion, and resistance anticipation. | Learn more |
| Rare Genetic Diseases | Pharma, biotech, and academic groups working in rare disease, neurodegenerative, cardiovascular, and other genetically defined disorders | Cell models and functional assays confirming pathogenicity and predicting therapeutic response. | Learn more |
| Compound–Target Assay | Med-chem teams developing small-molecule drugs | Residue-level resistance and sensitivity mapping for compound–target interactions. | Learn more |
| Custom Services | Teams whose needs fall outside our standard service shapes | Bespoke assay design — arrayed per-variant studies, tagging-based engagement assays, custom phenotypic endpoints. | Learn more |
| CRISPR Therapeutics | Developers of CRISPR-based therapies | Characterisation of bystander mutations, off-target effects, and unintended edits introduced by therapeutic editors. | Learn more |
Routing aid
Which service is right for you?
- Working on a cancer drug project? Start with Oncology
- Working on a project in rare genetic disease, neurodegenerative disease, cardiovascular disease, or another genetically defined disorder? Start with Rare Genetic Diseases
- Developing a small molecule and need residue-level interaction data? See Compound–Target Assay
- Developing a CRISPR-based therapy and need to characterise editing outcomes? See CRISPR Therapeutics
- Do not fit the above, or have a question that needs a custom assay? See Custom Services or book a meeting